HFE gene mutations and iron status of Brazilian blood donors

Brazilian Journal of Medical and Biological Research

Volumn 43, Issue 1, 2010, Pages 107-114

  Santos, P C J L ^a   Cancado R D ^b   Terada, C T ^a   Rostelato, S ^a   Gonzales, I ^a   Hirata, R D C ^a   Hirata, M H ^a   Chiattone, C S ^b   Guerra Shinohara, E M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Interdisciplinary Center for Clinical Neuromodulation   (Brazil)

Author keywords

Blood donors; Gene mutations; HFE; Iron status; TFR2

Indexed keywords

FERRITIN; HFE PROTEIN; IRON;

ADULT; ALLELE; ARTICLE; BLOOD DONOR; BRAZIL; FEMALE; FERRITIN BLOOD LEVEL; GENDER; GENE MUTATION; GENOTYPE; HETEROZYGOTE DETECTION; HOMOZYGOSITY; HUMAN; IRON BINDING CAPACITY; LINEAR REGRESSION ANALYSIS; MALE;

EID: 75649116831     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/s0100-879x2009007500031     Document Type: Article

References (37)

1. Swinkels DW, Janssen MC, Bergmans J, Marx JJ. Hereditary hemochromatosis: genetic complexity and new diagnostic approaches. Clin Chem 2006; 52: 950-968.
2. Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A 1998; 95: 1472-1477.
3. Fleming RE, Ahmann JR, Migas MC, Waheed A, Koeffler HP, Kawabata H, et al. Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis. Proc Natl Acad Sci U S A 2002; 99: 10653-10658.
4. Camaschella C, Roetto A, De Gobbi M. Genetic haemochromatosis: genes and mutations associated with iron loading. Best Pract Res Clin Haematol 2002; 15: 261-276.
5. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997; 34: 275-278.
6. Brissot P, Moirand R, Jouanolle AM, Guyader D, Le Gall JY, Deugnier Y, et al. A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria. J Hepatol 1999; 30: 588-593.
7. Carella M, D'Ambrosio L, Totaro A, Grifa A, Valentino MA, Piperno A, et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 1997; 60: 828-832.
8. Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ML, Franchini PL, Dube MP, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004; 36: 77-82.
9. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408.
10. Mura C, Raguenes O, Ferec C. HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 1999; 93: 2502-2505.
11. Beutler E. The significance of the 187G (H63D) mutation in hemochromatosis. Am J Hum Genet 1997; 61: 762-764.
12. Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000; 25: 14-15.
13. Mattman A, Huntsman D, Lockitch G, Langlois S, Buskard N, Ralston D, et al. Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutation. Blood 2002; 100: 1075-1077.
14. Agostinho MF, Arruda VR, Basseres DS, Bordin S, Soares MC, Menezes RC, et al. Mutation analysis of the HFE gene in Brazilian populations. Blood Cells Mol Dis 1999; 25: 324-327.
15. Bueno S, Duch CR, Figueiredo MS. Mutations in the HFE gene (C282Y, H63D, S65C) in a Brazilian population. Rev Bras Hematol Hemoter 2006; 28: 293-295.
16. Torres FR, Souza-Neiras WC, D'Almeida Couto AA, D'Almeida Couto VS, Cavasini CE, Rossit AR, et al. Frequency of the HFE C282Y and H63D polymorphisms in Brazilian malaria patients and blood donors from the Amazon region. Genet Mol Res 2008; 7: 60-64.
17. http://www.ibge.gov.br/home/estatistica/populacao/censo2000/. Accessed September 8, 2009.
18. Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SD. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci U S A 2003; 100: 177-182.
19. Vargens DD, Almendra L, Struchiner CJ, Suarez-Kurtz G. Distribution of the GNB3 825C>T polymorphism among Brazilians: impact of population structure. Eur J Clin Pharmacol 2008; 64: 253-256.
20. Agência Nacional de Vigilância Sanitária do Brasil. RDC 153, de 14 de junho de 2004. 〈http://www.anvisa.gov.br/sangue/legis/ 〉. Accessed September 8, 2009.
21. Salazar LA, Hirata MH, Cavalli SA, Machado MO, Hirata RD. Optimized procedure for DNA isolation from fresh and cryo-preserved clotted human blood useful in clinical molecular testing. Clin Chem 1998; 44: 1748-1750.
22. Best LG, Harris PE, Spriggs EL. Hemochromatosis mutations C282Y and H63D in 'cis' phase. Clin Genet 2001; 60: 68-72.
23. Roetto A, Totaro A, Piperno A, Piga A, Longo F, Garozzo G, et al. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood 2001; 97: 2555-2560.
24. Avila-Gomez IC, Aristizabal-Bernal B, Jimenez-Del-Rio M, Velez-Pardo C. Prevalence of H63D, S65C and C282Y mutations of the HFE gene in 1120 voluntary blood donors from Antioquia region of northwest Colombia. Blood Cells Mol Dis 2008; 40: 449-451.
25. Salvioni A, Mariani R, Oberkanins C, Moritz A, Mauri V, Pelucchi S, et al. Prevalence of C282Y and E168X HFE mutations in an Italian population of Northern European ancestry. Haematologica 2003; 88: 250-255.
26. Simonsen K, Dissing J, Rudbeck L, Schwartz M. Rapid and simple determination of hereditary haemochromatosis mutations by multiplex PCR-SSCP: detection of a new polymorphic mutation. Ann Hum Genet 1999; 63: 193-197.
27. Milman N, Steig T, Koefoed P, Pedersen P, Fenger K, Nielsen FC. Frequency of the hemochromatosis HFE mutations C282Y, H63D, and S65C in blood donors in the Faroe Islands. Ann Hematol 2005; 84: 146-149.
28. Mercier G, Bathelier C, Lucotte G. Frequency of the C282Y mutation of hemochromatosis in five French populations. Blood Cells Mol Dis 1998; 24: 165-166.
29. Pozzato G, Zorat F, Nascimben F, Gregorutti M, Comar C, Baracetti S, et al. Haemochromatosis gene mutations in a clustered Italian population: evidence of high prevalence in people of Celtic ancestry. Eur J Hum Genet 2001; 9: 445-451.
30. McLaren CE, Li KT, Garner CP, Beutler E, Gordeuk VR. Mixture distribution analysis of phenotypic markers reflecting HFE gene mutations. Blood 2003; 102: 4563-4566.
31. Pimenta JR, Zuccherato LW, Debes AA, Maselli L, Soares RP, Moura-Neto RS, et al. Color and genomic ancestry in Brazilians: a study with forensic microsatellites. Hum Hered 2006; 62: 190-195.
32. De Gobbi M, Barilaro MR, Garozzo G, Sbaiz L, Alberti F, Camaschella C. TFR2 Y250X mutation in Italy. Br J Haematol 2001; 114: 243-244.
33. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110: 1107-1119.
34. Barton JC, McDonnell SM, Adams PC, Brissot P, Powell LW, Edwards CQ, et al. Management of hemochromatosis. Hemochromatosis Management Working Group. Ann Intern Med 1998; 129: 932-939.
35. Terada CT, Santos PC, Cancado RD, Rostelato S, Lopreato FR, Chiattone CS, et al. Iron deficiency and frequency of HFE C282Y gene mutation in Brazilian blood donors. Transfus Med 2009; 19: 245-251.
36. Worwood M. Genetics of haemochromatosis. Baillieres Clin Haematol 1994; 7: 903-918.
37. Milman N, Sondergaard M. Iron stores in male blood donors evaluated by serum ferritin. Transfusion 1984; 24: 464-468.